These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 9649939)
1. Genetic risk factors for myocardial infarction. Marian AJ Curr Opin Cardiol; 1998 May; 13(3):171-8. PubMed ID: 9649939 [TBL] [Abstract][Full Text] [Related]
2. Common polymorphisms in the cannabinoid CB2 receptor gene (CNR2) are not associated with myocardial infarction and cardiovascular risk factors. Reinhard W; Stark K; Neureuther K; Sedlacek K; Fischer M; Baessler A; Weber S; Kaess B; Wiedmann S; Erdmann J; Lieb W; Jeron A; Riegger G; Hengstenberg C Int J Mol Med; 2008 Aug; 22(2):165-74. PubMed ID: 18636169 [TBL] [Abstract][Full Text] [Related]
3. Vascular and haemostatic gene polymorphisms associated with non-fatal myocardial infarction: a critical review. Manzoli A; Andreotti F; Leone AM; Sperti G; Zecchi P; Di Sciascio G Ital Heart J; 2000 Mar; 1(3):184-93. PubMed ID: 10806985 [TBL] [Abstract][Full Text] [Related]
4. Genetic screening of candidate genes for a prothrombotic interaction with type I protein C deficiency in a large kindred. Scott BT; Bovill EG; Callas PW; Hasstedt SJ; Leppert MF; Valliere JE; Varvil TS; Long GL Thromb Haemost; 2001 Jan; 85(1):82-7. PubMed ID: 11204593 [TBL] [Abstract][Full Text] [Related]
5. Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or beta-blocker use and the risk of myocardial infarction and stroke. Schelleman H; Klungel OH; Witteman JC; Breteler MM; Hofman A; van Duijn CM; de Boer A; Stricker BH Pharmacogenomics J; 2008 Dec; 8(6):400-7. PubMed ID: 18347611 [TBL] [Abstract][Full Text] [Related]
6. Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease. Baessler A; Fischer M; Mayer B; Koehler M; Wiedmann S; Stark K; Doering A; Erdmann J; Riegger G; Schunkert H; Kwitek AE; Hengstenberg C Hum Mol Genet; 2007 Apr; 16(8):887-99. PubMed ID: 17324965 [TBL] [Abstract][Full Text] [Related]
7. Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction. French JK; Van de Water NS; Sutton TM; Lund M; Gao W; McDowell J; Liu-Stratton Y; Pohorence J; Szymanski D; Goldschmidt-Clermont P; White HD; Browett PJ; Cooke G Am Heart J; 2003 Jan; 145(1):118-24. PubMed ID: 12514663 [TBL] [Abstract][Full Text] [Related]
8. Genetic risk factors in myocardial infarction at young age. Incalcaterra E; Hoffmann E; Averna MR; Caimi G Minerva Cardioangiol; 2004 Aug; 52(4):287-312. PubMed ID: 15284679 [TBL] [Abstract][Full Text] [Related]
9. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers. Schelleman H; Klungel OH; Witteman JC; Breteler MM; Yazdanpanah M; Danser AH; Hofman A; van Duijn CM; de Boer A; Stricker BH Eur J Hum Genet; 2007 Apr; 15(4):478-84. PubMed ID: 17299437 [TBL] [Abstract][Full Text] [Related]
10. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Broeckel U; Hengstenberg C; Mayer B; Holmer S; Martin LJ; Comuzzie AG; Blangero J; Nürnberg P; Reis A; Riegger GA; Jacob HJ; Schunkert H Nat Genet; 2002 Feb; 30(2):210-4. PubMed ID: 11818963 [TBL] [Abstract][Full Text] [Related]
12. Evidence of major genes effects on serum homocysteine and fibrinogen levels, and premature ischemic heart disease in Italian extended families. Grassi M; Kisialiou A; Assanelli D; Mozzini C; Archetti S; Pezzini A Hum Hered; 2008; 66(1):50-60. PubMed ID: 18223316 [TBL] [Abstract][Full Text] [Related]
13. [Genetics of preeclampsia: an approach to genetic linkage studies]. Zuluaga NA; Cuartas JM; Londoño JG Biomedica; 2004 Jun; 24(2):207-25. PubMed ID: 15495602 [TBL] [Abstract][Full Text] [Related]
14. Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels. Gigante B; Vikström M; Meuzelaar LS; Chernogubova E; Silveira A; Hooft FV; Hamsten A; de Faire U Thromb Haemost; 2009 May; 101(5):943-53. PubMed ID: 19404549 [TBL] [Abstract][Full Text] [Related]
15. Association of gene polymorphisms with myocardial infarction in individuals with or without conventional coronary risk factors. Nishihama K; Yamada Y; Matsuo H; Segawa T; Watanabe S; Kato K; Yajima K; Hibino T; Yokoi K; Ichihara S; Metoki N; Yoshida H; Satoh K; Nozawa Y Int J Mol Med; 2007 Jan; 19(1):129-41. PubMed ID: 17143557 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population. Román-García P; Coto E; Reguero JR; Cannata-Andía JB; Lozano I; Avanzas P; Morís C; Rodríguez I Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856 [TBL] [Abstract][Full Text] [Related]
20. "My parents died of myocardial infarction: is that my destiny?". Narula N; Rapezzi C; Tavazzi L; Arbustini E Med Clin North Am; 2012 Jan; 96(1):67-86. PubMed ID: 22391252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]